Publication | Open Access
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer
58
Citations
39
References
2018
Year
This trial ( NCT03493945 ) was registered in National Clinical Trials on April 11th 2018.
| Year | Citations | |
|---|---|---|
Page 1
Page 1